Skip to main content

Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

Publication ,  Journal Article
Aby, ES; Moafa, G; Latt, N; Sultan, MT; Cacioppo, PA; Kumar, S; Chung, RT; Bloom, PP; Gustafson, J; Daidone, M; Reinus, Z; Debes, JD; Zhou, K ...
Published in: Hepatol Commun
January 1, 2023

BACKGROUND: COVID-19 is associated with higher morbidity and mortality in patients with chronic liver diseases (CLDs). However, our understanding of the long-term outcomes of COVID-19 in patients with CLD is limited. METHODS: We conducted a multicenter, observational cohort study of adult patients with CLD who were diagnosed with COVID-19 before May 30, 2020, to determine long-term clinical outcomes. We used a control group of patients with CLD confirmed negative for COVID-19. RESULTS: We followed 666 patients with CLD (median age 58 years, 52.8% male) for a median of 384 (interquartile range: 31-462) days. The long-term mortality was 8.1%; with 3.6% experiencing delayed COVID-19-related mortality. Compared to a propensity-matched control group of patients with CLD without COVID-19 (n=1332), patients with CLD with COVID-19 had worse long-term survival [p<0.001; hazards ratio (HR): 1.69; 95% CI: 1.19-2.41] and higher rate of hospitalization (p<0.001, HR: 2.00, 1.62-2.48) over a 1-year follow-up period. Overall, 29.9% of patients reported symptoms of long-COVID-19. On multivariable analysis, female sex (p=0.05, HR: 2.45, 1.01-2.11), Hispanic ethnicity (p=0.003, HR: 1.94, 1.26-2.99), and severe COVID-19 requiring mechanical ventilation (p=0.028, HR: 1.74, 1.06-2.86) predicted long-COVID-19. In survivors, liver-related laboratory parameters showed significant improvement after COVID-19 resolution. COVID-19 vaccine status was available for 72% (n=470) of patients with CLD and history of COVID-19, of whom, 70% (n=326) had received the COVID-19 vaccine. CONCLUSIONS: Our large, longitudinal, multicenter study demonstrates a high burden of long-term mortality and morbidity in patients with CLD and COVID-19. Symptoms consistent with long-COVID-19 were present in 30% of patients with CLD. These results illustrate the prolonged implications of COVID-19 both for recovering patients and for health care systems.

Duke Scholars

Published In

Hepatol Commun

DOI

EISSN

2471-254X

Publication Date

January 1, 2023

Volume

7

Issue

1

Start / End Page

e8874

Location

United States

Related Subject Headings

  • Post-Acute COVID-19 Syndrome
  • Middle Aged
  • Male
  • Liver Diseases
  • Humans
  • Hospitalization
  • Female
  • COVID-19 Vaccines
  • COVID-19
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aby, E. S., Moafa, G., Latt, N., Sultan, M. T., Cacioppo, P. A., Kumar, S., … Dhanasekaran, R. (2023). Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun, 7(1), e8874. https://doi.org/10.1097/01.HC9.0000897224.68874.de
Aby, Elizabeth S., Ghady Moafa, Nyan Latt, Mohammad T. Sultan, Paula A. Cacioppo, Sonal Kumar, Raymond T. Chung, et al. “Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.Hepatol Commun 7, no. 1 (January 1, 2023): e8874. https://doi.org/10.1097/01.HC9.0000897224.68874.de.
Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, et al. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun. 2023 Jan 1;7(1):e8874.
Aby, Elizabeth S., et al. “Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.Hepatol Commun, vol. 7, no. 1, Jan. 2023, p. e8874. Pubmed, doi:10.1097/01.HC9.0000897224.68874.de.
Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, Chung RT, Bloom PP, Gustafson J, Daidone M, Reinus Z, Debes JD, Sandhu S, Sohal A, Khalid S, Roytman M, Catana AM, Wegermann K, Carr RM, Saiman Y, Kassab I, Chen VL, Rabiee A, Rosenberg C, Nguyen V, Gainey C, Zhou K, Chavin K, Lizaola-Mayo BC, Chascsa DM, Varelas L, Moghe A, Dhanasekaran R. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun. 2023 Jan 1;7(1):e8874.

Published In

Hepatol Commun

DOI

EISSN

2471-254X

Publication Date

January 1, 2023

Volume

7

Issue

1

Start / End Page

e8874

Location

United States

Related Subject Headings

  • Post-Acute COVID-19 Syndrome
  • Middle Aged
  • Male
  • Liver Diseases
  • Humans
  • Hospitalization
  • Female
  • COVID-19 Vaccines
  • COVID-19
  • Adult